Structure/Function of Mitochondrial Citrate Carrier
线粒体柠檬酸盐载体的结构/功能
基本信息
- 批准号:7932586
- 负责人:
- 金额:$ 13.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:Amino AcidsAntibodiesAwardBindingBinding SitesBioenergeticsCarrier ProteinsChargeChemicalsCitratesClassificationCouplingCrystallizationCrystallographyCysteineDetergentsDiabetes MellitusDiseaseDockingElectrostaticsEnergy MetabolismEngineeringEukaryotic CellFab ImmunoglobulinsFoundationsGenerationsGrowthHealthHomology ModelingIndividualInner mitochondrial membraneKineticsLaboratoriesLettersLigandsLipidsLocationMalignant NeoplasmsManualsMapsMeasuresMembraneMembrane ProteinsMetabolismMethodologyMethodsMitochondriaModelingModificationMolecularMolecular ConformationMolecular StructureMonoclonal AntibodiesMovementMutagenesisMutateMutationNaturePathologyPathway interactionsPhasePhosphoenolpyruvatePlayPositioning AttributePreparationProceduresProductionPropertyProteinsProtocols documentationReagentRelative (related person)Research PersonnelResolutionRoentgen RaysRoleScanningScreening procedureSeriesSideSiteSolventsSpin LabelsStructureStructure-Activity RelationshipSubstrate SpecificitySulfhydryl CompoundsSurfaceTertiary Protein StructureTestingTransmembrane DomainTransport ReactionWaterX ray diffraction analysisX-Ray Diffractionantiporterbasecitrate carriercrosslinkdefined contributiondesigndicarboxylatedimerflexibilityinhibitor/antagonistinsightinterestmethanethiosulfonatemolecular dynamicsmonomermutantprogramsprotein functionprotein structureresearch studytricarboxylate
项目摘要
DESCRIPTION (provided by applicant): The long-term objective of this project is to understand the relationship between the molecular structure of the mitochondrial citrate transport protein (CTP) and its mechanism of transport. This transporter catalyzes the exchange of tricarboxylates, dicarboxylates, and phosphoenolpyruvate across the inner mitochondrial membrane, and as such is essential to the energy metabolism of eukaryotic cells. Recently, we: i) conducted cysteine scanning mutagenesis studies of transmembrane domains (TMDs) HI and IV which, in combination with chemical modification, nitroxide scanning, and substrate protection experiments, permitted identification of essential portions of the substrate translocation pathway; ii) developed a homology model of the CTP structure; and iii) developed methods for the purification of the CTP in crystallization-compatible detergents, which enabled the initiation of comprehensive crystallization trials. From this foundation, we propose to launch studies that will continue the fundamental advancement in our understanding of the functioning of this metabolically important transporter. Specifically, experiments will be conducted to: i) define the contributions of the four remaining TMDs in the formation of the CTP substrate translocation pathway (via cysteine-substitution mutagenesis at locations chosen on the basis of our homology modeled CTP structure followed by chemical modification of the single Cys mutants) and identify residues forming an electrostatic funnel that attracts citrate into the pathway from its surfaces; ii) identify the substrate binding site(s) within the translocation pathway and assess the ability of selected CTP domains to control substrate access to the pathway; iii) identify residues forming the interface between two CTP monomers in homodimeric CTP and characterize the ligand-induced conformational changes that occur during transport using site-directed spin labeling and thiol cross-linking; and iv) identify conditions enabling the growth of X-ray diffraction quality CTP crystals followed by determination of the CTP structure. These studies will provide a comprehensive understanding of the chemical and structural bases for mitochondrial CTP function. The health relatedness of this project concerns the central role of the CTP in bioenergetics. Thus, altered CTP function in disease (e.g., diabetes, cancer) is an important aspect of the aberrant metabolism that characterizes these pathologies. Consequently, an elucidation of the structural basis for substrate transport through the CTP is critical to understanding the CTP's role in energy production in normal and pathological states.
描述(由申请人提供):该项目的长期目标是了解线粒体柠檬酸转运蛋白(CTP)的分子结构及其转运机制之间的关系。该转运蛋白催化三羧酸盐、二羧酸盐和磷酸烯醇丙酮酸穿过线粒体内膜的交换,因此对于真核细胞的能量代谢至关重要。最近,我们: i) 对跨膜结构域 (TMD) HI 和 IV 进行半胱氨酸扫描诱变研究,结合化学修饰、硝基氧扫描和底物保护实验,可以鉴定底物易位途径的重要部分; ii) 开发了CTP结构的同源模型; iii) 开发了在结晶相容洗涤剂中纯化 CTP 的方法,从而启动了全面的结晶试验。在此基础上,我们建议开展研究,以继续从根本上推进我们对这种代谢重要转运蛋白功能的理解。具体来说,将进行实验:i) 定义其余四个 TMD 在 CTP 底物易位途径形成中的贡献(通过在我们的同源模型 CTP 结构的基础上选择的位置进行半胱氨酸取代诱变,然后对单个 Cys 突变体进行化学修饰),并鉴定形成静电漏斗的残基,该漏斗将柠檬酸盐从其表面吸引到途径中; ii) 识别易位途径内的底物结合位点并评估选定的 CTP 结构域控制底物进入该途径的能力; iii) 鉴定同二聚体 CTP 中两个 CTP 单体之间形成界面的残基,并使用定点自旋标记和硫醇交联表征运输过程中发生的配体诱导的构象变化; iv) 确定能够生长 X 射线衍射质量 CTP 晶体的条件,然后确定 CTP 结构。这些研究将提供对线粒体 CTP 功能的化学和结构基础的全面了解。该项目的健康相关性涉及 CTP 在生物能学中的核心作用。因此,疾病(例如糖尿病、癌症)中 CTP 功能的改变是表征这些病理的异常代谢的一个重要方面。因此,阐明通过 CTP 进行底物运输的结构基础对于理解 CTP 在正常和病理状态下能量产生中的作用至关重要。
项目成果
期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Oligomeric state of wild-type and cysteine-less yeast mitochondrial citrate transport proteins.
野生型和无半胱氨酸酵母线粒体柠檬酸转运蛋白的寡聚状态。
- DOI:10.1023/a:1005460810527
- 发表时间:1999
- 期刊:
- 影响因子:3
- 作者:Kotaria,R;Mayor,JA;Walters,DE;Kaplan,RS
- 通讯作者:Kaplan,RS
The yeast mitochondrial citrate transport protein: determination of secondary structure and solvent accessibility of transmembrane domain IV using site-directed spin labeling.
酵母线粒体柠檬酸转运蛋白:使用定点自旋标记确定跨膜结构域 IV 的二级结构和溶剂可及性。
- DOI:10.1021/bi000433e
- 发表时间:2000
- 期刊:
- 影响因子:2.9
- 作者:Kaplan,RS;Mayor,JA;Kotaria,R;Walters,DE;McHaourab,HS
- 通讯作者:McHaourab,HS
Mitochondrial and Plasma Membrane Citrate Transporters: Discovery of Selective Inhibitors and Application to Structure/Function Analysis.
- DOI:
- 发表时间:2010-06
- 期刊:
- 影响因子:0
- 作者:Jiakang Sun;Sreevidya Aluvila;R. Kotaria;J. Mayor;D. Walters;R. S. Kaplan
- 通讯作者:Jiakang Sun;Sreevidya Aluvila;R. Kotaria;J. Mayor;D. Walters;R. S. Kaplan
The yeast mitochondrial citrate transport protein: identification of the Lysine residues responsible for inhibition mediated by Pyridoxal 5'-phosphate.
酵母线粒体柠檬酸转运蛋白:鉴定负责吡哆醛 5-磷酸介导的抑制作用的赖氨酸残基。
- DOI:10.1007/s10863-008-9187-1
- 发表时间:2008
- 期刊:
- 影响因子:3
- 作者:Remani,Sreevidya;Sun,Jiakang;Kotaria,Rusudan;Mayor,JuneA;Brownlee,JuneM;Harrison,DavidHT;Walters,DEric;Kaplan,RonaldS
- 通讯作者:Kaplan,RonaldS
Probing the effect of transport inhibitors on the conformation of the mitochondrial citrate transport protein via a site-directed spin labeling approach.
通过定点自旋标记方法探讨转运抑制剂对线粒体柠檬酸转运蛋白构象的影响。
- DOI:10.1007/s10863-010-9280-0
- 发表时间:2010
- 期刊:
- 影响因子:3
- 作者:Mayor,JuneA;Sun,Jiakang;Kotaria,Rusudan;Walters,DEric;Oh,KyoungJoon;Kaplan,RonaldS
- 通讯作者:Kaplan,RonaldS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ronald Sloan Kaplan其他文献
Ronald Sloan Kaplan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ronald Sloan Kaplan', 18)}}的其他基金
STRUCTURE/FUNCTION OF MITOCHONDRIAL CITRATE CARRIER
线粒体柠檬酸盐载体的结构/功能
- 批准号:
6195750 - 财政年份:1996
- 资助金额:
$ 13.05万 - 项目类别:
STRUCTURE/FUNCTION OF MITOCHONDRIAL CITRATE CARRIER
线粒体柠檬酸盐载体的结构/功能
- 批准号:
6019179 - 财政年份:1996
- 资助金额:
$ 13.05万 - 项目类别:
Structure/Function of Mitochondrial Citrate Carrier
线粒体柠檬酸盐载体的结构/功能
- 批准号:
7028926 - 财政年份:1996
- 资助金额:
$ 13.05万 - 项目类别:
STRUCTURE/FUNCTION OF MITOCHONDRIAL CITRATE CARRIER
线粒体柠檬酸盐载体的结构/功能
- 批准号:
6636202 - 财政年份:1996
- 资助金额:
$ 13.05万 - 项目类别:
STRUCTURE/FUNCTION OF MITOCHONDRIAL CITRATE CARRIER
线粒体柠檬酸盐载体的结构/功能
- 批准号:
2734806 - 财政年份:1996
- 资助金额:
$ 13.05万 - 项目类别:
Structure/Function of Mitochondrial Citrate Carrier
线粒体柠檬酸盐载体的结构/功能
- 批准号:
7217880 - 财政年份:1996
- 资助金额:
$ 13.05万 - 项目类别:
STRUCTURE/FUNCTION OF MITOCHONDRIAL CITRATE CARRIER
线粒体柠檬酸盐载体的结构/功能
- 批准号:
2610737 - 财政年份:1996
- 资助金额:
$ 13.05万 - 项目类别:
STRUCTURE/FUNCTION OF MITOCHONDRIAL CITRATE CARRIER
线粒体柠檬酸盐载体的结构/功能
- 批准号:
6386540 - 财政年份:1996
- 资助金额:
$ 13.05万 - 项目类别:
Structure/Function of Mitochondrial Citrate Carrier
线粒体柠檬酸盐载体的结构/功能
- 批准号:
6920207 - 财政年份:1996
- 资助金额:
$ 13.05万 - 项目类别:
Structure/Function of Mitochondrial Citrate Carrier
线粒体柠檬酸盐载体的结构/功能
- 批准号:
7390878 - 财政年份:1996
- 资助金额:
$ 13.05万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 13.05万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 13.05万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 13.05万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 13.05万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 13.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 13.05万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 13.05万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 13.05万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 13.05万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 13.05万 - 项目类别:














{{item.name}}会员




